Effects of radiotherapy on different histopathological types of rectal carcinoma

Colorectal Disease

Volumn 8, Issue 4, 2006, Pages 283-288

  Sengul, N ^a   Wexner, S D ^a   Woodhouse, S ^a   Arrigain, S ^b   Xu, M ^b   Larach, J A ^a   Ahn, B K ^a   Weiss, E G ^a   Nogueras, J J ^a   Berho, D M ^a  

^a DEPARTMENT OF COLORECTAL SURGERY   (United States)

^b LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Chemoradiotherapy; Mucinous; Neoadjuvant; Rectal carcinoma

Indexed keywords

FLUOROURACIL;

ADULT; AGED; ARTICLE; CANCER CLASSIFICATION; CANCER RADIOTHERAPY; CANCER REGRESSION; CANCER STAGING; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MUCINOUS CARCINOMA; PREOPERATIVE CARE; PRIORITY JOURNAL; PROGNOSIS; RECTUM BIOPSY; RECTUM CARCINOMA; RECTUM RESECTION; SCORING SYSTEM; TRANSRECTAL ULTRASONOGRAPHY; TREATMENT OUTCOME;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; ANTIMETABOLITES, ANTINEOPLASTIC; FEMALE; FLUOROURACIL; HUMANS; MALE; MIDDLE AGED; NEOADJUVANT THERAPY; NEOPLASM STAGING; RADIOTHERAPY, ADJUVANT; RECTAL NEOPLASMS; REMISSION INDUCTION; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 33645732257     PISSN: 14628910     EISSN: 14631318     Source Type: Journal    
DOI: 10.1111/j.1463-1318.2005.00934.x     Document Type: Article

References (42)

1. Rich T, Gunderson LL, Lew R et al. Patterns of recurremce of rectal cancer after potentially curative surgery. Cancer 1983; 52: 1317.
2. Quirke P, Durdey P, Nixon MF et al. Local recurrence of rectal adenocarcinoma due to inadequate surgical excision. Histopathological study of lateral tumor spread and surgical excision. Lancet 1986; 2: 996.
3. Pahlman L, Grimelius B. Local recurrence after surgical treatment for rectal carcinoma. Acta Chir Scand 1984; 150: 331.
4. Havenga K, Enger WE, Norstein J et al. Improved survival and local control after total mesorectal excision or D3 lymphadenectomy in the treatment of primary rectal cancer: An international analysis of 1411 patients. Eur J Surg Oncol 1992; 28: 368.
5. Nesbakken A, Nygaard K, Westerheim O et al. Local recurrence after mesorectal excision for rectal cancer. Eur J Surg Oncol 2002; 26: 350.
6. Kapiteijn E, Marijnen CA, Nagtegaal ID et al. Dutch colorectal cancer group. Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. N Eng J Med 2001; 345: 638.
7. Camma C, Giunta M, Fiorica F et al. Preoperative radiotherapy for resectable rectal cancer: A meta analysis. J Am Med Assoc 2000; 284: 1008.
8. Colorectal cancer collaborative group. Adjuvant radiotherapy for rectal cancer. a systematic overview of 8057 patients from 22 randomized trials. Lancet 2001; 358: 1291.
9. Meagher AP. Radiotherapy for rectal cancer. N Eng J Med 2002; 345: 137.
10. Marijnen CAM, Kapiteijn E, van der Velde CJH. Acute side effects and complications after short term preoperative radiotherapy compared with total mesorectal excision in primary rectal cancer: Report of a multicenter randomized trial. J Clin Oncol 2002; 20: 817-825.
11. Allal AS, Bieri S, Pelloni A et al. Sphincter-sparing surgery after preoperative radiotherapy for low rectalcancers: Feasibility, oncologic results and quality of life outcomes. Br J Cancer 2000; 82: 1131.
12. Wagman R, Minsky BD, Cohen AM et al. Sphincter preservation in rectal cancer with preoperative radiation therapy and coloanal anastomsis: Long term follow-up. Int J Radiat Oncol Biol Phys 1998; 42: 51.
13. Valentini V, Coco C, Cellini N et al. Ten years of preoperative chemoradiation for extraperitoneal T3 rectal cancer: Acute toxicity, tumor response and sphincter preservation in three consecutive studies. Int J Radiat Oncol Biol Phys 2001; 51: 371.
14. Grann A, Minsky BD Cohen Am, et al. Preliminary results of preoperative 5-fluorouracil, low dose leucovorin, and concurrent radiation therapy for clinically resectable T3 rectal cancer. Dis Colon Rectum 1997; 40: 515.
15. Janjan NA, Crane CN, Fieg BW et al. Prospective trial of preoperative concomitant boost radiotherapy with continuous infusion 5-fluorouracil for locally advanced rectal cancer. Int J Radiat Oncol Biol Phys 2000; 47: 713.
16. Ruo L, Tickoo S, Klimstra D et al. Long term prognostic significance of extent of rectal cancer response to preoperative radiation and chemotherapy. Ann Surg 2002; 236: 75.
17. Moore H, Guillem JG. Multimodality Management of Locally Advanced Rectal Cancer. The Am Surgeon 2003; 69: 612.
18. Jass JR, Sobin LH (1989 2nd edition) Histological Typing of Intestinal Tumours: World Health Organization. Springer-Verlag NY Inc., New York.
19. Mandard AM, Dalibard F, Mandard JC et al. Pathologic assessment of tumor regression after preoperative chemoradiotherapy of esophageal carcinoma. Clinicopathologic correlations. Cancer 1994; 73: 2680.
20. Parham D. Colloid Carcinoma. Ann Surg 1923; 77: 90.
21. Symonds DA, Vickery AL. Mucinous carcinoma of the colon and rectum. Cancer 1976; 37: 1891.
22. Zhang H, Evertsson S, Sun XF. Clinicopathological and genetic characteristics of mucinous carcinomas of the colorectum. Int J Oncol 1999; 14: 1057.
23. de Mascarel A, Coindre JM, de Macarel I et al. The prognostic significance of specific histologic features of carcinoma of the colon and rectum. Surg Gynecol Obstet 1981; 153: 511.
24. Consorti F, Lorenzotti A, Midiri G. Prognostic significance of mucinous carcinoma of colon and rectum: A prospective case control study. J Surg Oncol 2000; 73: 70.
25. Minsky BD, Mies C, Rich TA et al. Colloid carcinoma of the colon and rectum. Cancer 1987; 60: 3103.
26. Adell R, Marcote E, Segarra V. Is mucinous colorectal adenocarcinoma a distinct entity? Gastroenterol Hepatol 2002; 25: 534.
27. Bouzourene H, Bosman F, Matter M. Predictive factors in locally advanced rectal cancer trated with preoperative hyperfractionated and accelerated radiotherapy. Hum Pathol 2003; 34: 541.
28. Berger C, de Muret A, Garaud P et al. Preoperative radiotherapy of rectal cancer. Predictive factors of tumor downstaging and residual tumor cell density (RTCD): Prognostic implications. Int J Radiat Oncol Biol Phys 1997; 37: 619.
29. Gerard JP, Chapet O, Morignat E et al. Preoperative radiotherapy for rectal cancer. The Lyons exprerience, 1985-96. Prognostic apropos of 312 patients. Ann Chir 1999; 53: 1003.
30. Kaminsky-Forrett MC, Conroy T, Luporsi E et al. Prognostic implication of downstaging following preoperative radiation for operable T3-T4 rectal cancer. Int J Radiat Oncol Biol Phys 1998; 42: 935.
31. Dworak O, Keilholz L, Hoffmann A. Pathological features of rectal cancer after preoperative radiochemotherapy. Int J Colorectal Dis 1997; 12: 19.
32. Wheeler JM, Warren BF, Jones AC, Mortensen NJ. Preoperative radiotherapy for rectal cancer: Implications for surgeons, pathologists and radiologists. Br J Surg 1999; 86: 1108.
33. Wheeler JM, Warren BF, Mortensen NJ et al. Quantification of histologic regression of rectal cancer after irradiation: A proposal for a modified staging system. Dis Colon Rectum 2002; 45: 1051.
34. Shia J, Guillem JG, Moore HG et al. Patterns of orphologic alteration in residual rectal carcinoma following preoperative chemoradiation and their association with long-term outcome. Am J Surg Pathol 2004; 28: 215.
35. Nagtegaal ID, Marijnen CA, Kranenbarg EK et al. Pathology Review Committee. Short-term preoperative radiotherapy interferes with the determination of pathological parameters in rectal cancer. J Pathol 2002; 197: 20.
36. Moore HG, Gittleman AE, Minsky BD et al. Rate of pathologic complete response with increased interval between preoperative combined modality therapy and rectal cancer resection. Dis Colon Rectum 2004; 47: 279.
37. Grillo-Ruggieri F, Mantello G, Cardinali M et al. Down-staging after two different preoperative chemoradiation schedules in rectal cancer. Tumori 2003; 89: 164.
38. Rullier A, Laurent C, Vendrely V, Le Bail B, Bioulac-Sage P, Rullier E. Impact of colloid response on survival after preoperative radiotherapy in locally advanced rectal carcinoma. Am J Surg Pathol 2005; 29: 602.
39. Nagtegaal I, Gaspar C, Marijnen C, Van De Velde C, Fodde R, Van Krieken H. Morphological changes in tumour type after radiotherapy are accompanied by changes in gene expression profile but not in clinical behaviour. J Pathol 2004; 204: 183.
40. Kanazawa T, Watanabe T, Kazama T et al. Poorly differentiated adenocarcinoma and mucinous carcinoma of the colon and rectum show higher rates of loss of heterozygosity and loss of E-cadherin expression due to methylation of promoter region. Int J Cancer 2002; 102: 225.
41. Hussain SM, Outwater EK, Siegelman ES. Mucinous versus nonmucinous rectal carcinomas: Differentiation with MR imaging. Radiology 1999; 213: 79.
42. Kim MJ, Park JS, Park SI et al. Accuracy in differentiation of mucinous and nonmucinous rectal carcinoma on MR imaging. J Comput Assist Tomogr 2003; 27: 48.